AOD 9604, a modified human growth hormone fragment, is studied in metabolic research for its potential to promote fat metabolism, support lipolysis, regulate metabolism, and aid cartilage repair, offering insights into obesity management without influencing growth proliferation.
This product does have cloudy appearance but is safe to use.
Molecular Formula: C78H123N23O23S2
Molecular Weight: 1763.1 g/mol
Purity: 99%
For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, and must not be misused in any way that contravenes MHRA regulations or applicable laws.
AOD-9604 is a fragment of the human growth hormone developed for the treatment of obesity. It is designed to mimic the fat-burning properties of hGH without its muscle-building effects or the common side effects.
This is achieved through Tyrosine (TYR), a portion of the amino acid sequence responsible for fat reduction and tissue repair. It mimics the effects of hGH on lipid metabolism without promoting growth or triggering pro-diabetic effects.
Where GLP-1 agonists suppress appetite and influence insulin secretion, AOD-9604 inhibits lipoprotein lipase activity in fat tissue, stimulating lipolysis in adipocytes. It specifically targets areas of the body with high fat deposits, preventing the conversion of carbohydrates into triglycerides and fatty acids and blocking the process of lipogenesis.
AOD-9604 can be particularly useful when stacked with GLP-1s to combat plateaus and target stubborn fat that diet and exercise alone may not eliminate.
Additional Benefits
Increases metabolism
Stimulates lipolysis
Inhibits lipogenesis (formation of fat cells)
Promotes bone and cartilage repair
Improves bone strength
Does not impact blood sugar levels
Enhances collagen production and skin elasticity
Possesses anti-inflammatory properties (beneficial for arthritis)
Enhances joint flexibility and mobility
Prevents medication-related muscle-wasting
Possible Side Effects
Injection site reactions (redness, swelling, itching)
Headache
Fatigue
Dizziness
Cough
Chest tightness or constriction
Heart palpitations
Cold-like symptoms
Contraindications
Do not use AOD-9604 if you are pregnant or breastfeeding.
AOD-9604 and GLP-1s It is strongly recommended that individuals taking GLP-1 medications who still have 30+ pounds to lose, or who are slow responders or have plateaued, consider adding AOD-9604 to their protocol for a minimum of 3 months. The combination may significantly improve outcomes.
This website uses cookies to improve your experience. By clicking “Deny”, you consent to the use of Necessary cookies only. You may also accept selected cookies only.
